| 30/03/23 | 15:51:17 | 30 Mar 2023 | | PDS Update |
| 28/03/23 | 15:50:03 | 28 Mar 2023 | | PDS Business Update and 2022 Financial Results |
| 28/02/23 | 07:00:05 | 28 Feb 2023 | | Related party loan to ProAxsis Limited |
| 27/02/23 | 15:28:26 | 27 Feb 2023 | | PDS completes FDA meeting for triple combination |
| 10/02/23 | 14:05:21 | 10 Feb 2023 | | Second Price Monitoring Extn |
| 10/02/23 | 14:00:10 | 10 Feb 2023 | | Price Monitoring Extension |
| 10/02/23 | 11:05:35 | 10 Feb 2023 | | Second Price Monitoring Extn |
| 10/02/23 | 11:00:25 | 10 Feb 2023 | | Price Monitoring Extension |
| 01/02/23 | 07:00:09 | 1 Feb 2023 | | Board Change |
| 03/01/23 | 13:31:17 | 3 Jan 2023 | | PDS Announces Exclusive Global License Agreement |
| 28/12/22 | 15:05:26 | 28 Dec 2022 | | PDS Biotech: Median Overall Survival announcement |
| 16/12/22 | 07:00:04 | 16 Dec 2022 | | PDS: HPV16 Head and Neck Cancer announcement |
| 12/12/22 | 14:00:00 | 12 Dec 2022 | | Board Changes; Options; Co-Investment Agreement |
| 29/11/22 | 07:00:08 | 29 Nov 2022 | | EMV C leads £4.2m round in 5G and SATCOM leader |
| 14/11/22 | 14:50:40 | 14 Nov 2022 | | PDS Q3 Results and Business Update |
| 14/11/22 | 14:05:42 | 14 Nov 2022 | | Second Price Monitoring Extn |
| 14/11/22 | 14:00:23 | 14 Nov 2022 | | Price Monitoring Extension |
| 09/11/22 | 07:00:08 | 9 Nov 2022 | | Board Change |
| 07/11/22 | 15:40:57 | 7 Nov 2022 | | PDS reports presentation of data at cancer society |
| 20/10/22 | 07:00:05 | 20 Oct 2022 | | EMV Capital secures investment in Ventive |
| 11/10/22 | 16:00:08 | 11 Oct 2022 | | PDS Update |
| 03/10/22 | 13:56:42 | 3 Oct 2022 | | PDS completes End-of-Phase 2 meeting with FDA |
| 30/09/22 | 07:00:17 | 30 Sept 2022 | | Half-year Report |
| 25/08/22 | 07:00:04 | 25 Aug 2022 | | PDS Completes $35 Million Financing Agreement |
| 16/08/22 | 07:00:11 | 16 Aug 2022 | | Acquisition of 30% Vortex stake & new Vortex CEO |
| 08/08/22 | 16:45:32 | 8 Aug 2022 | | PDS Reports Q2 2022 Results & Business Update |
| 29/06/22 | 14:05:15 | 29 Jun 2022 | | Result of AGM |
| 28/06/22 | 09:15:30 | 28 Jun 2022 | | Holding(s) in Company |
| 27/06/22 | 08:30:01 | 27 Jun 2022 | | Director/PDMR Shareholding |
| 27/06/22 | 08:30:01 | 27 Jun 2022 | | Holding(s) in Company |
| 22/06/22 | 07:00:07 | 22 Jun 2022 | | Result of Placing and Total Voting Rights |
| 21/06/22 | 16:41:41 | 21 Jun 2022 | | Proposed Placing to raise at least £1.5 million |
| 17/06/22 | 12:00:52 | 17 Jun 2022 | | NetScientific to increase Q-Bot stake to 23.7% |
| 15/06/22 | 07:00:04 | 15 Jun 2022 | | Q-Bot secures £1.6m of investment to fund growth |
| 07/06/22 | 11:07:05 | 7 Jun 2022 | | Notice of AGM and Annual Report & Accounts |
| 06/06/22 | 07:00:09 | 6 Jun 2022 | | PDS Granted FDA Fast Track Designation for PDS0101 |
| 27/05/22 | 14:39:11 | 27 May 2022 | | PDS Biotech - new data for ongoing clinical trials |
| 19/05/22 | 07:00:07 | 19 May 2022 | | General Counsel Strategic Hire & Grant of Options |
| 16/05/22 | 07:00:07 | 16 May 2022 | | ProAxsis Update |
| 12/05/22 | 07:00:05 | 12 May 2022 | | Final Results |
| 11/05/22 | 15:46:51 | 11 May 2022 | | PDS Reports Q1 2022 Results & Business Update |
| 09/05/22 | 07:00:07 | 9 May 2022 | | Notice of Results & Investor Presentation |
| 06/05/22 | 07:00:06 | 6 May 2022 | | Acquisition of 30% of Vortex Biotech Holdings |
| 25/04/22 | 14:05:35 | 25 Apr 2022 | | Second Price Monitoring Extn |
| 25/04/22 | 14:00:40 | 25 Apr 2022 | | Price Monitoring Extension |
| 25/04/22 | 11:05:46 | 25 Apr 2022 | | Second Price Monitoring Extn |
| 25/04/22 | 11:00:49 | 25 Apr 2022 | | Price Monitoring Extension |
| 31/03/22 | 13:24:03 | 31 Mar 2022 | | PDS Provides Business Update & Full-Year Results |
| 04/03/22 | 07:30:07 | 4 Mar 2022 | | Publication of Shareholder Newsletter |
| 24/02/22 | 16:45:51 | 24 Feb 2022 | | PDS Announces Preliminary Safety Data on PDS0101 |
